Offer - Urjas Oil for just ₹ 1 X
Go 3 is a prescription drug, available for use as Drops. Conjunctivitis are some of its major therapeutic uses. Secondary and off-label uses of Go 3 have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Go 3. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Go 3 also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Dizziness. Besides the aforementioned side effects, there are other adverse effects of Go 3 as well, which are listed below. Such side effects of Go 3 normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Go 3 has a Moderate effect for pregnant women and Severe effect on lactating mothers. In addition, Go 3's effects on the liver, heart and kidney are discussed below in the Go 3 related warnings section.
Go 3 is not recommended if you suffer from certain medical conditions as it can have adverse effects. Myasthenia Gravis (MG), Brain and Nervous System, Tendon Injury (Tendinopathy) are examples of such conditions. Other contraindications of Go 3 have been discussed in the sections ahead.
Drug reaction of Go 3 with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Go 3 is safe while driving, and is is addictive in nature.
Go 3 is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Go 3 safe for pregnant women?
Go 3 may have some side effects during pregnancy. Pregnant women should discontinue the use of Go 3, and talk to their doctor, if they notice any discomfort.
Is the use of Go 3 safe during breastfeeding?
Taking Go 3 may lead to serious side effects if you are breastfeeding. Go 3 should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Go 3 on the Kidneys?
Using Go 3 does not have any harmful effects on kidneys.
What is the effect of Go 3 on the Liver?
Go 3 does not damage the liver.
What is the effect of Go 3 on the Heart?
You can take Go 3 without any fear of damage to the heart.
Go 3 should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Go 3 unless your doctor advises you to do so -
Is this Go 3 habit forming or addictive?
Go 3 is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Go 3 since it does not cause drowsiness.
Is it safe?
No, Go 3 is not completely safe.
Is it able to treat mental disorders?
No, Go 3 is not used to treat mental disorders.
Interaction between Food and Go 3
Go 3 may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Go 3
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Go 3.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZymaxidY™ (gatifloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399